Your patient stories highlight that GLP one medications help some, harm some and are unnecessary for many
When used in patients experiencing lower GI symptoms while taking GLP-1 medications, ARM allows clinicians to: Differentiate between drug-related motility effects and true pelvic floor dysfunction Quantify the severity of anorectal dysfunction to support diagnosis and treatment planning Establish a baseline prior to initiating biofeedback or behavioral therapy Monitor progress if conservative management is pursued Persistent Constipation in GLP-1 Users ARM can determine if dyssynergic defecation is contributing to delayed evacuation, guiding appropriate therapy beyond simply adjusting medication
387, no
DECLARATIONS Authors contributions Performed literature search, review writing, data analysis, and interpretation: Ding M Made significant contributions to the conception, design, and revision of the manuscript: Luo Y Proposed the rationale and framework of review, provided guidance for manuscript design: Ji L Availability of data and materials Not applicable
If it stays small and improves within a day or two, it is often part of the same short-lived reaction pattern as mild redness or stinging
